bisoprolol has been researched along with Cardiomyopathy, Dilated in 30 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
Cardiomyopathy, Dilated: A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the effect of beta1-selective blocker bisoprolol on the QT and QTc dispersion in patients with chronic heart failure and to compare the responses to bisoprolol in patients with different etiologies." | 9.09 | Effect of bisoprolol on QT dispersion in patients with congestive heart failure--the etiology-dependent response. ( Chen, Y; Li, XP; Peng, DQ; Zhao, SP, 2001) |
| "Bisoprolol was administered orally at doses of 1." | 5.29 | [Clinical effects of bisoprolol in congestive heart failure due to dilated cardiomyopathy]. ( Li, L; Li, Z, 1995) |
| "The authors performed a double-blinded, placebo-controlled, multicenter trial to compare the effect of bisoprolol with that of placebo on 1-yr composite outcome including cardiovascular mortality, nonfatal myocardial infarction, unstable angina, congestive heart failure, and cerebrovascular insult." | 5.12 | Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: a double-blinded, placebo-contro ( Bestmann, L; Blumenthal, S; Boltres, A; Borgeat, A; Furrer, L; Hersberger, M; Hofer, C; Kälin, G; Lucchinetti, E; Müller, A; Schulz, C; Spahn, DR; Wacker, J; Zaugg, M; Zollinger, A, 2007) |
| "To evaluate the effect of beta1-selective blocker bisoprolol on the QT and QTc dispersion in patients with chronic heart failure and to compare the responses to bisoprolol in patients with different etiologies." | 5.09 | Effect of bisoprolol on QT dispersion in patients with congestive heart failure--the etiology-dependent response. ( Chen, Y; Li, XP; Peng, DQ; Zhao, SP, 2001) |
| "Bisoprolol was administered as the first drug in 10 patients and diltiazem was administered in 8." | 2.68 | Comparison of the therapeutic effects of the beta-blocking agent bisoprolol and the calcium-blocking agent diltiazem in patients with heart failure due to dilated cardiomyopathy. ( Hirota, Y; Ito, T; Kawamura, K; Moriguchi, A; Otake, Y; Suwa, M, 1996) |
| "Bisoprolol was well tolerated without between group difference in premature treatment withdrawals (82 on placebo, 75 on bisoprolol; NS)." | 2.67 | A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees. ( , 1994) |
| "It remains unclear whether dilated cardiomyopathy (DCM) is a primary feature of ATS." | 1.43 | Reversible Dilated Cardiomyopathy Caused by a High Burden of Ventricular Arrhythmias in Andersen-Tawil Syndrome. ( Duff, HJ; Ferrier, RA; Gerull, B; Guo, J; Rezazadeh, S, 2016) |
| "Treatment with bisoprolol prevented the progression of cardiac dysfunction in TO-2 hamsters." | 1.33 | Attenuation of oxidative stress and cardiac dysfunction by bisoprolol in an animal model of dilated cardiomyopathy. ( Hashimoto, K; Ichihara, G; Ichihara, S; Iwase, M; Kanazawa, H; Kato, Y; Matsushita, A; Oikawa, S; Yamada, Y; Yokota, M, 2006) |
| "Treatment of perindopril and bisoprolol could reverse myocardial hypertrophy and changes in DCM rats." | 1.32 | Alteration of endothelin system and calcium handling protein in left ventricles following drug treatment in dilated cardiomyopathy rats. ( Chen, XJ; Fang, WW; Geng, Q; Wu, XH; Yang, D; Zhang, JN, 2003) |
| "Idiopathic dilated cardiomyopathy is a severe disease of unknown etiology." | 1.31 | Protective effect of bisoprolol on beta-1 adrenoceptor peptide-induced autoimmune myocardial damage in rabbits. ( Fu, HM; Fu, ML; Hayase, M; Katsuda, S; Kurihara, T; Matsui, S; Persson, M; Teraoka, K, 2000) |
| "These bradyarrhythmias were atrioventricular block, sick sinus syndrome and atrial fibrillation with slow heart rate." | 1.30 | Effect of beta-blocker treatment in dilated cardiomyopathy with bradyarrhythmias. ( Hirota, Y; Ito, T; Kawamura, K; Kobashi, A; Otake, Y; Suwa, M, 1998) |
| "Bisoprolol was administered orally at doses of 1." | 1.29 | [Clinical effects of bisoprolol in congestive heart failure due to dilated cardiomyopathy]. ( Li, L; Li, Z, 1995) |
| "Treatment with bisoprolol was helpful in maintaining an acceptable functional status and in preventing multiple shocks until transplantation became mandatory." | 1.29 | Familial dilated cardiomyopathy and spontaneous ventricular arrhythmias. ( Caes, F; de Pauw, M; Jordaens, L, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (33.33) | 18.2507 |
| 2000's | 16 (53.33) | 29.6817 |
| 2010's | 4 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dominguez-Rodriguez, A | 1 |
| Abreu-Gonzalez, P | 1 |
| Consuegra-Sanchez, L | 1 |
| Avanzas, P | 1 |
| Tanaka, H | 1 |
| Matsumoto, K | 1 |
| Sawa, T | 1 |
| Miyoshi, T | 1 |
| Motoji, Y | 1 |
| Imanishi, J | 1 |
| Mochizuki, Y | 1 |
| Tatsumi, K | 1 |
| Hirata, K | 1 |
| Rezazadeh, S | 1 |
| Guo, J | 1 |
| Duff, HJ | 1 |
| Ferrier, RA | 1 |
| Gerull, B | 1 |
| Haberland, A | 1 |
| Wallukat, G | 2 |
| Dahmen, C | 1 |
| Kage, A | 1 |
| Schimke, I | 1 |
| Kolb, C | 1 |
| Lehmann, G | 1 |
| Schreieck, J | 1 |
| Ndrepepa, G | 1 |
| Schmitt, C | 1 |
| Zhang, JN | 1 |
| Geng, Q | 1 |
| Chen, XJ | 1 |
| Fang, WW | 1 |
| Wu, XH | 1 |
| Yang, D | 1 |
| Fukuchi, K | 1 |
| Yasumura, Y | 1 |
| Kiso, K | 1 |
| Hayashida, K | 1 |
| Miyatake, K | 1 |
| Ishida, Y | 1 |
| Chen, J | 1 |
| Larsson, L | 1 |
| Haugen, E | 1 |
| Fedorkova, O | 1 |
| Angwald, E | 1 |
| Waagstein, F | 1 |
| Fu, M | 1 |
| Ichihara, S | 1 |
| Yamada, Y | 1 |
| Ichihara, G | 1 |
| Kanazawa, H | 1 |
| Hashimoto, K | 1 |
| Kato, Y | 1 |
| Matsushita, A | 1 |
| Oikawa, S | 1 |
| Yokota, M | 1 |
| Iwase, M | 1 |
| Zaugg, M | 1 |
| Bestmann, L | 1 |
| Wacker, J | 1 |
| Lucchinetti, E | 1 |
| Boltres, A | 1 |
| Schulz, C | 1 |
| Hersberger, M | 1 |
| Kälin, G | 1 |
| Furrer, L | 1 |
| Hofer, C | 1 |
| Blumenthal, S | 1 |
| Müller, A | 1 |
| Zollinger, A | 1 |
| Spahn, DR | 1 |
| Borgeat, A | 1 |
| Body, SC | 1 |
| Schwinn, DA | 1 |
| Wakita, T | 1 |
| Numata, Y | 1 |
| Ogata, Y | 1 |
| Harada, E | 1 |
| Mizumasa, Y | 1 |
| Lechat, P | 2 |
| Yamada, S | 1 |
| Ohkura, T | 1 |
| Uchida, S | 1 |
| Inabe, K | 1 |
| Iwatani, Y | 1 |
| Kimura, R | 1 |
| Hoshino, T | 1 |
| Kaburagi, T | 1 |
| Li, Z | 1 |
| Li, L | 1 |
| Jordaens, L | 1 |
| de Pauw, M | 1 |
| Caes, F | 1 |
| Suwa, M | 4 |
| Ito, T | 4 |
| Otake, Y | 3 |
| Moriguchi, A | 2 |
| Hirota, Y | 4 |
| Kawamura, K | 4 |
| Adachi, I | 1 |
| Narabayashi, I | 1 |
| Kobashi, A | 2 |
| Anthonio, RL | 2 |
| Brouwer, J | 1 |
| Haaksma, J | 1 |
| van der Ven, L | 1 |
| van Veldhuisen, DJ | 2 |
| Crijns, HJ | 2 |
| van Gilst, WH | 2 |
| Breekland, A | 1 |
| Yagi, H | 1 |
| Terasaki, F | 1 |
| Garlichs, C | 1 |
| Daniel, WG | 1 |
| Matsui, S | 1 |
| Persson, M | 1 |
| Fu, HM | 1 |
| Hayase, M | 1 |
| Katsuda, S | 1 |
| Teraoka, K | 1 |
| Kurihara, T | 1 |
| Fu, ML | 1 |
| Nyolczas, N | 1 |
| Dekány, M | 1 |
| Fiók, J | 1 |
| Prëda, I | 1 |
| Peng, DQ | 1 |
| Zhao, SP | 1 |
| Chen, Y | 1 |
| Li, XP | 1 |
| Ohtsuka, T | 1 |
| Hamada, M | 1 |
| Hiasa, G | 1 |
| Sasaki, O | 1 |
| Suzuki, M | 1 |
| Hara, Y | 1 |
| Shigematsu, Y | 1 |
| Hiwada, K | 1 |
| Nissen, E | 1 |
| Jedliński, I | 1 |
| Michalski, M | 1 |
| Dankowski, R | 1 |
| Poprawski, K | 1 |
| Wierzchowiecki, M | 1 |
| Ozegowski, S | 1 |
| Pawlak, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Collaborative Systematic Overview of Randomised Controlled Trials of Beta-Blockers in the Treatment of Heart Failure[NCT00832442] | 18,240 participants (Anticipated) | Observational | 2008-08-31 | Enrolling by invitation | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for bisoprolol and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
[Adrenergic betablockers and heart failure].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Cardiomyopathy, Dilated; Heart Failure; Humans; Metoprolol; | 1995 |
7 trials available for bisoprolol and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
Gated myocardial SPECT to predict response to beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Bisoprolol; Carbazoles; Cardiomyopathy, Dilat | 2004 |
Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: a double-blinded, placebo-contro
Topics: Adrenergic beta-Antagonists; Anesthesia, Spinal; Bisoprolol; Cardiomyopathy, Dilated; Cardiovascular | 2007 |
[The relationship between the improvement of cardiac function and the myocardial uptake of I-123 metaiodobenzylguanidine in patients with dilated cardiomyopathy treated by beta-blocker].
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Adult; Bisoprolol; Cardiomyopathy, Dilated; Exer | 1995 |
A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Cardiac Output, Low; Cardiomyopathy, Dilated; Dose-Response | 1994 |
Comparison of the therapeutic effects of the beta-blocking agent bisoprolol and the calcium-blocking agent diltiazem in patients with heart failure due to dilated cardiomyopathy.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Bisoprolol; Blood Pressure; Calcium Channel Bl | 1996 |
Prediction of the effect of bisoprolol in dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Analysis of Variance; Bisoprolol; Blood Pressure; Cardiomy | 2000 |
Effect of bisoprolol on QT dispersion in patients with congestive heart failure--the etiology-dependent response.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Cardiomyopathy, Dilated; Female; Heart Conduction Sys | 2001 |
22 other studies available for bisoprolol and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
Ivabradine might improve exercise capacity in dilated cardiomyopathy in comparison with bisoprolol: assessment with the ergospirometry test.
Topics: Adrenergic beta-Antagonists; Benzazepines; Bisoprolol; Cardiomyopathy, Dilated; Cardiotonic Agents; | 2014 |
Evaluation of global circumferential strain as prognostic marker after administration of β-blockers for dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Area Under Curve; Bisoprolol; Carbazoles; Cardiomyopathy, | 2014 |
Reversible Dilated Cardiomyopathy Caused by a High Burden of Ventricular Arrhythmias in Andersen-Tawil Syndrome.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Andersen Syndrome; Bisoprolol; Cardiomyopathy, Dilate | 2016 |
Aptamer neutralization of beta1-adrenoceptor autoantibodies isolated from patients with cardiomyopathies.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-1 Receptor Antagonists; Animals; Antibody Speci | 2011 |
Storms of ventricular tachyarrhythmias associated with primary hyperparathyroidism in a patient with dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Anti-Arrhythmia Agents; Bisoprolol; Cardiomyopathy, Dilated; Def | 2003 |
Alteration of endothelin system and calcium handling protein in left ventricles following drug treatment in dilated cardiomyopathy rats.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bisoprolol; Calcium | 2003 |
Effects of autoantibodies removed by immunoadsorption from patients with dilated cardiomyopathy on neonatal rat cardiomyocytes.
Topics: Adrenergic beta-Antagonists; Animals; Animals, Newborn; Antibody-Dependent Cell Cytotoxicity; Autoan | 2006 |
Attenuation of oxidative stress and cardiac dysfunction by bisoprolol in an animal model of dilated cardiomyopathy.
Topics: Aldehydes; Animals; Antioxidants; Bisoprolol; Blood Pressure; Body Weight; Cardiomyopathy, Dilated; | 2006 |
Limitations of genetic findings that are not in Hardy-Weinberg equilibrium.
Topics: Adrenergic beta-Antagonists; Anesthesia, Spinal; Bisoprolol; Cardiomyopathy, Dilated; Cardiovascular | 2008 |
A sustained increase in beta-adrenoceptors during long-term therapy with metoprolol and bisoprolol in patients with heart failure from idiopathic dilated cardiomyopathy.
Topics: Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Bisoprolol; Cardio | 1996 |
[Clinical effects of bisoprolol in congestive heart failure due to dilated cardiomyopathy].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Bisoprolol; Cardiomyopathy, Dilated; Depression, Chemical; | 1995 |
Familial dilated cardiomyopathy and spontaneous ventricular arrhythmias.
Topics: Adolescent; Adult; Bisoprolol; Cardiomyopathy, Dilated; Defibrillators, Implantable; Electrocardiogr | 1996 |
Iodine-123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to beta-blocker therapy in patients with dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Bisoprolol; Cardiomyopa | 1997 |
Effect of beta-blocker treatment in dilated cardiomyopathy with bradyarrhythmias.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Bisoprolol; Bradycardia; Ca | 1998 |
Different effects of bisoprolol on heart rate in patients with ischemic or idiopathic dilated cardiomyopathy (a 24-hour Holter substudy of the Cardiac Insufficiency Bisoprolol Study [CIBIS]).
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Bisoprolol; Cardiomyopathy, Dilated; Circadian | 1999 |
Beta-blocker titration failure is independent of severity of heart failure.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Bisoprolol; Blood Pressure; Cardiac Catheteriz | 2000 |
Myocardial integrated ultrasonic backscatter in patients with dilated cardiomyopathy: prediction of response to beta-blocker therapy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Biopsy; Bisoprolol; Cardiomyopathy, Dilated; Echocardiogra | 2000 |
[New milestones in the therapy of chronic heart failure with beta blockers].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; Carbazoles; Cardi | 2000 |
Protective effect of bisoprolol on beta-1 adrenoceptor peptide-induced autoimmune myocardial damage in rabbits.
Topics: Adrenergic beta-Antagonists; Animals; Autoimmune Diseases; Bisoprolol; Cardiac Volume; Cardiomyopath | 2000 |
Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Bisoprolol; Cardiomyopathy, Dilated; Cytokines; Drug Thera | 2001 |
Anti beta1-adrenoceptor autoantibodies analyzed in spontaneously beating neonatal rat heart myocyte cultures-comparison of methods.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Animals, Newborn; Autoantibodies; Bi | 2001 |
Transoesophageal Doppler echocardiography provided important parameters in patients with dilated cardiomyopathy during bisoprolol therapy.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Cardiomyopathy, Dilated; Coronary Circulation; Echoca | 2002 |